Looking At Merck & Co., Inc. (NYSE:MRK) From All Angles

Attractive stocks have exceptional fundamentals. In the case of Merck & Co., Inc. (NYSE:MRK), there's is a well-regarded dividend payer with a strong history of delivering benchmark-beating performance. In the following section, I expand a bit more on these key aspects. For those interested in digging a bit deeper into my commentary, take a look at the report on Merck here.

Advertisement

Solid track record established dividend payer

MRK delivered a triple-digit bottom-line expansion over the past couple of years, with its most recent earnings level surpassing its average level over the last five years. This illustrates a strong track record, leading to a satisfying return on equity of 33%, which is an optimistic signal for the future.

NYSE:MRK Income Statement, August 16th 2019
NYSE:MRK Income Statement, August 16th 2019

For those seeking income streams from their portfolio, MRK is a robust dividend payer as well. Over the past decade, the company has consistently increased its dividend payout, reaching a yield of 2.6%.

NYSE:MRK Historical Dividend Yield, August 16th 2019
NYSE:MRK Historical Dividend Yield, August 16th 2019

Next Steps:

For Merck, there are three essential factors you should further examine:

  1. Future Outlook: What are well-informed industry analysts predicting for MRK’s future growth? Take a look at our free research report of analyst consensus for MRK’s outlook.
  2. Financial Health: Are MRK’s operations financially sustainable? Balance sheets can be hard to analyze, which is why we’ve done it for you. Check out our financial health checks here.
  3. Other Attractive Alternatives : Are there other well-rounded stocks you could be holding instead of MRK? Explore our interactive list of stocks with large potential to get an idea of what else is out there you may be missing!

We aim to bring you long-term focused research analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.

If you spot an error that warrants correction, please contact the editor at editorial-team@simplywallst.com. This article by Simply Wall St is general in nature. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Simply Wall St has no position in the stocks mentioned. Thank you for reading.

About NYSE:MRK

Merck

Operates as a healthcare company worldwide.

Reasonable growth potential with adequate balance sheet and pays a dividend.

Advertisement

Weekly Picks

LO
Lou_Basenese
CUE logo
Lou_Basenese on Cue Biopharma ·

Cue Biopharma (NASDAQ: CUE): The Scientist Behind Xolair Just Gave Cue a Next-Generation Shot at the Same Multi-Billion-Dollar Market

Fair Value:US$7065.0% undervalued
42 users have followed this narrative
0 users have commented on this narrative
8 users have liked this narrative
HA
HarishPK
ADBE logo
HarishPK on Adobe ·

Adobe: A Probabilistic Case for Undervaluation

Fair Value:US$319.9636.2% undervalued
46 users have followed this narrative
8 users have commented on this narrative
16 users have liked this narrative
NI
niteco
AVGO logo
niteco on Broadcom ·

A Capital Allocation Favorite with Structural Importance

Fair Value:US$651.0541.3% undervalued
45 users have followed this narrative
0 users have commented on this narrative
8 users have liked this narrative
TO
Tokyo
OKTA logo
Tokyo on Okta ·

Good foundation, but now it's all about the next steps

Fair Value:US$15123.0% undervalued
91 users have followed this narrative
7 users have commented on this narrative
11 users have liked this narrative

Updated Narratives

TA
Talos
AMD logo
Talos on Advanced Micro Devices ·

The "David vs. Goliath" AI Trade – Why Second Place is Worth Billions

Fair Value:US$907.3243.6% undervalued
35 users have followed this narrative
1 users have commented on this narrative
0 users have liked this narrative
JA
Janpeo
SPCX logo
Janpeo on Space Exploration Technologies ·

The trap for retailers that can evaporate more than 80% of the value.

Fair Value:US$28.55463.7% overvalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
AS
AstrisCorporateAdvisory
7095 logo
AstrisCorporateAdvisory on Macbee Planet ·

Approaching an inflection point

Fair Value:JP¥1.08k7.2% undervalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative

Popular Narratives

MA
martinarauz
NU logo
martinarauz on Nu Holdings ·

Investment Analysis (May 2026)

Fair Value:US$22.7446.4% undervalued
66 users have followed this narrative
0 users have commented on this narrative
16 users have liked this narrative
CL
Clive_Thompson
TTWO logo
Clive_Thompson on Take-Two Interactive Software ·

Take-Two Interactive: The Calm Before the Storm NASDAQ: TTWO Last Price: $242.41 Date: May 15, 2026

Fair Value:US$276.9723.5% undervalued
58 users have followed this narrative
0 users have commented on this narrative
14 users have liked this narrative
NI
niteco
HON logo
niteco on Honeywell International ·

Honeywell - The Demand-Side of the AI Infrastructure

Fair Value:US$320.1931.2% undervalued
50 users have followed this narrative
0 users have commented on this narrative
19 users have liked this narrative